z-logo
open-access-imgOpen Access
Sirolimus Stimulates Vascular Stem/Progenitor Cell Migration and Differentiation Into Smooth Muscle Cells via Epidermal Growth Factor Receptor/Extracellular Signal–Regulated Kinase/β-Catenin Signaling Pathway
Author(s) -
Mei Mei Wong,
Bernhard Winkler,
Eirini Karamariti,
Xiaocong Wang,
Baoqi Yu,
Russell Simpson,
Ting Chen,
Andriani Margariti,
Qingbo Xu
Publication year - 2013
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.113.301595
Subject(s) - progenitor cell , microbiology and biotechnology , neointima , cancer research , stem cell , epidermal growth factor , biology , vascular endothelial growth factor , endothelial progenitor cell , medicine , receptor , restenosis , biochemistry , stent , vegf receptors
Sirolimus-eluting stent therapy has achieved considerable success in overcoming coronary artery restenosis. However, there remain a large number of patients presenting with restenosis after the treatment, and the source of its persistence remains unclarified. Although recent evidence supports the contribution of vascular stem/progenitor cells in restenosis formation, their functional and molecular responses to sirolimus are largely unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom